Sponsor Pipeline

Trans Tasman Radiation Oncology Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
1
Phase 3
3
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07135882
Primary Radiotherapy In MEtastatic Lung Cancer		 date change Primary completion pushed: 2029-01-01 -> 2030-12-31
2026-08-01 NCT07135882
Primary Radiotherapy In MEtastatic Lung Cancer		 date change Completion pushed: 2033-01-01 -> 2036-12-31
Active Trials by Phase
Phase 3
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07135882 Primary Radiotherapy In MEtastatic Lung Cancer Carcinoma, Non-Small-Cell Lung (NSCLC) Not Yet Recruiting
Phase 2
NCT04319783 Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA Advanced Prostate Carcinoma Active, Not Recruiting
NCT05796089 Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic… Extensive-Stage Small-Cell Lung Cancer Active, Not Recruiting
Not specified
NCT00860652 Radiotherapy - Adjuvant Versus Early Salvage Prostate Cancer Active, Not Recruiting
Disease Areas
Prostate Cancer (2) Lung Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Trans Tasman Radiation Oncology Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free